| Name | Title | Contact Details |
|---|---|---|
Neil Ayotte |
Senior Vice President, General Counsel and Chief Compliance Officer | Profile |
Htv Systems Ltd is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
ACUFOCUS, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
MedShift, founded in 2015 in Charlotte, NC delivers platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 250 providers in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems. MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians and their business. MedShift`s broad portfolio of services for practices includes a portfolio of 24 leading aesthetic medical devices from six manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across manufacturer and provider spectrum and continues to empower robust integration with leading brands and doctors in the industry.
Compumedics is a El Paso, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs). EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease -- namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.